Bernstein Remains a Buy on Dexcom (DXCM)

Tip Ranks
2025.12.13 16:55
portai
I'm PortAI, I can summarize articles.

Bernstein's Lee Hambright maintains a Buy rating on Dexcom with a price target of $84.00, while the stock closed at $66.96. The analyst consensus is a Strong Buy with an average price target of $85.75, indicating a 28.06% upside. Citi also maintains a Buy rating with a $77.00 target. Hambright has a 6.9% average return and a 61.18% success rate on stocks.

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Dexcom, with a price target of $84.00. The company’s shares closed yesterday at $66.96.

Claim 50% Off TipRanks Premium and Invest with Confidence

  • Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
  • Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential

Hambright covers the Healthcare sector, focusing on stocks such as Intuitive Surgical, Insulet, and Medtronic. According to TipRanks, Hambright has an average return of 6.9% and a 61.18% success rate on recommended stocks.

Currently, the analyst consensus on Dexcom is a Strong Buy with an average price target of $85.75, which is a 28.06% upside from current levels. In a report released yesterday, Citi also maintained a Buy rating on the stock with a $77.00 price target.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.